O U R  P L A T F O R M

We exist to radically solve the unforgiving need for cell, tissue, and organ transplantation

—for all humankind.

  • Distinct from other wound care products, Xeno-Skin™ offers the advantage of the inclusion of live cells, which allow it to temporarily incorporate with the patient’s own body, promoting more efficient, effective healing.

  • The safety data from the current Phase I trial (severe burns, orphan indication) can be used to demonstrate safety and tolerability for a wide range of indications.

  • A Phase II trial for efficacy is planned for 2021.

skin.png
skin.png
  • Our Xeno-Genomics™ program is designed to achieve a "patient-specific" transplantation solution by designing the ideal porcine donor through specific, pragmatic genetic alterations.

  • A broad array of cellular therapies could be derived to address countless other diseases, in addition to the conventional solid organ solutions such as heart, kidney,  and liver.

  • Xeno-Genomics™ in vitro proof-of-concept data available in 2020.

genomics.png
genomics.png

PATIENTS ARE WAITING ON US

Contact Us

Thanks for submitting!

Artboard 1_3x.png
Contact Information
Tel: 603-260-8945

Email: info@xenotherapeutics.com